newsfilter
← Latest News
GlobeNewswire·

Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026

BOSTON, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (NASDAQ:AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory